close
Add to watchlist
Cambrex Corp (CBM) Healthcare, Biotechnology & Drugs
Cambrex Corporation, a life sciences company, provides products and services to develop and commercialize active pharmaceutical ingredients and advanced intermediates. Its products include active pharmaceutical ingredients and pharmaceutical intermediates for use in the production of prescription and over-the-counter drug products, and other custom chemicals derived from organic chemistry. The company sells its products through direct sales and independent agents to pharmaceutical and generic drug companies worldwide. Cambrex Corporation was founded in 1981 and is based in East Rutherford, New Jersey.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 6.76 |
| Volume | 100345 |
| Volume Avg | 327847 |
| 52 Week High | 8.44 |
| 52 Week Low | 3.87 |
| PE | 19.56 |
| PE (group average) | 39 |
| EPS Year | 0.37 |
| EPS change Q/Q | -43.75% |
| EPS change Q/Q Yr ago | 50% |
| EPS change Q/Q next Q est | -50% |
| EPS change Y/Y | -27.78% |
| REV change Q/Q | -6.63% |
| REV change Q/Q Yr ago | 8.02% |
| EPS next Q est | 0.18 |
| EPS next Y est | 0.64 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |